UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 143

Sortiert nach

Exosomes Promote Ovarian Cancer Cell Invasion through Transfer of CD44 to Peritoneal Mesothelial Cells

Molecular cancer research, 2017-01, Vol.15 (1), p.78-92

2017

Link zum Volltext

Verfügbarkeit prüfen

The Role of MicroRNAs in Ovarian Cancer

BioMed research international, 2014-01, Vol.2014, p.249393-11

2014

Link zum Volltext

Verfügbarkeit prüfen

Clinical relevance of circulating cell-free microRNAs in ovarian cancer

Molecular cancer, 2016-06, Vol.15 (1), p.48-48, Article 48

2016

Link zum Volltext

Verfügbarkeit prüfen

Exosomal miR-99a-5p is elevated in sera of ovarian cancer patients and promotes cancer cell invasion by increasing fibronectin and vitronectin expression in neighboring peritoneal mesothelial cells

BMC cancer, 2018-11, Vol.18 (1), p.1065-1065, Article 1065

2018

Link zum Volltext

Verfügbarkeit prüfen

Interleukin 6 receptor is an independent prognostic factor and a potential therapeutic target of ovarian cancer

PloS one, 2015-02, Vol.10 (2), p.e0118080-e0118080

2015

Link zum Volltext

Verfügbarkeit prüfen

Prognostic significance of bone marrow FDG uptake in patients with gynecological cancer

Scientific reports, 2021-01, Vol.11 (1), p.2257-11, Article 2257

2021

Link zum Volltext

Verfügbarkeit prüfen

The significance of G-CSF expression and myeloid-derived suppressor cells in the chemoresistance of uterine cervical cancer

Scientific reports, 2015-12, Vol.5 (1), p.18217-18217, Article 18217

2015

Link zum Volltext

Verfügbarkeit prüfen

Potential of Integrin Inhibitors for Treating Ovarian Cancer: A Literature Review

Cancers, 2017-07, Vol.9 (7), p.83

2017

Link zum Volltext

Verfügbarkeit prüfen

In vivo loss-of-function screens identify KPNB1 as a new druggable oncogene in epithelial ovarian cancer

Proceedings of the National Academy of Sciences - PNAS, 2017-08, Vol.114 (35), p.E7301-E7310

2017

Link zum Volltext

Verfügbarkeit prüfen

Pathophysiological Role and Potential Therapeutic Exploitation of Exosomes in Ovarian Cancer

Cells (Basel, Switzerland), 2020-03, Vol.9 (4), p.814

2020

Link zum Volltext

Verfügbarkeit prüfen

Role of the Exosome in Ovarian Cancer Progression and Its Potential as a Therapeutic Target

Cancers, 2019-08, Vol.11 (8), p.1147

2019

Link zum Volltext

Verfügbarkeit prüfen

The Highly Metastatic Nature of Uterine Cervical/Endometrial Cancer Displaying Tumor-Related Leukocytosis: Clinical and Preclinical Investigations

Clinical cancer research, 2018-08, Vol.24 (16), p.4018-4029

2018

Link zum Volltext

Verfügbarkeit prüfen

Loss of E-Cadherin Promotes Ovarian Cancer Metastasis via α5-Integrin, which Is a Therapeutic Target

Cancer research (Chicago, Ill.), 2008-04, Vol.68 (7), p.2329-2339

2008

Link zum Volltext

Verfügbarkeit prüfen

Identification of Malignant Cell Populations Associated with Poor Prognosis in High-Grade Serous Ovarian Cancer Using Single-Cell RNA Sequencing

Cancers, 2022-07, Vol.14 (15), p.3580

2022

Link zum Volltext

Verfügbarkeit prüfen

The hypoxia-related microRNA miR-199a-3p displays tumor suppressor functions in ovarian carcinoma

Oncotarget, 2015-05, Vol.6 (13), p.11342-11356

2015

Link zum Volltext

Verfügbarkeit prüfen

miR-92a Inhibits Peritoneal Dissemination of Ovarian Cancer Cells by Inhibiting Integrin α5 Expression

The American journal of pathology, 2013-05, Vol.182 (5), p.1876-1889

2013

Link zum Volltext

Verfügbarkeit prüfen

Preclinical Investigations of PM01183 (Lurbinectedin) as a Single Agent or in Combination with Other Anticancer Agents for Clear Cell Carcinoma of the Ovary

PloS one, 2016-03, Vol.11 (3), p.e0151050-e0151050

2016

Link zum Volltext

Verfügbarkeit prüfen

Paclitaxel exposure downregulates miR-522 expression and its downregulation induces paclitaxel resistance in ovarian cancer cells

Scientific reports, 2020-10, Vol.10 (1), p.16755, Article 16755

2020

Link zum Volltext

Verfügbarkeit prüfen

Prostaglandin E2 produced by myeloid-derived suppressive cells induces cancer stem cells in uterine cervical cancer

Oncotarget, 2018-11, Vol.9 (91), p.36317-36330

2018

Link zum Volltext

Verfügbarkeit prüfen

Patient-Derived Exosomes as siRNA Carriers in Ovarian Cancer Treatment

Cancers, 2024-04, Vol.16 (8), p.1482

2024

Link zum Volltext

Verfügbarkeit prüfen

Exosomal miR-1290 is a potential biomarker of high-grade serous ovarian carcinoma and can discriminate patients from those with malignancies of other histological types

Journal of ovarian research, 2018-09, Vol.11 (1), p.81-81, Article 81

2018

Link zum Volltext

Verfügbarkeit prüfen

Sleeping Beauty Transposon Mutagenesis Identifies Genes Driving the Initiation and Metastasis of Uterine Leiomyosarcoma

Cancer research (Chicago, Ill.), 2021-11, Vol.81 (21), p.5413-5424

2021

Link zum Volltext

Verfügbarkeit prüfen

Foretinib (GSK1363089), an Orally Available Multikinase Inhibitor of c-Met and VEGFR-2, Blocks Proliferation, Induces Anoikis, and Impairs Ovarian Cancer Metastasis

Clinical cancer research, 2011-06, Vol.17 (12), p.4042-4051

2011

Link zum Volltext

Verfügbarkeit prüfen

Complicated pancreatic fistula after gynecologic surgery for left fallopian tube carcinosarcoma: A case report

Case reports in women's health, 2024-03, Vol.41, p.e00589, Article e00589

2024

Link zum Volltext

Verfügbarkeit prüfen

mTOR Is a Promising Therapeutic Target Both in Cisplatin-Sensitive and Cisplatin-Resistant Clear Cell Carcinoma of the Ovary

Clinical cancer research, 2009-09, Vol.15 (17), p.5404-5413

2009

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 143

Suche als RSS-Feed

Aktive Filter

KollektionEZB Electronic Journals Library

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(117)
Mit Volltextzugriff
(141)

Publikationsform

Artikel
(139)
Berichte
(4)

Sprache

Englisch
(138)
Japanisch
(47)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Exosomes Promote Ovarian Cancer Cell Invasion through Transfer of CD44 to Peritoneal Mesothelial Cells

The Role of MicroRNAs in Ovarian Cancer

Clinical relevance of circulating cell-free microRNAs in ovarian cancer

Exosomal miR-99a-5p is elevated in sera of ovarian cancer patients and promotes cancer cell invasion by increasing fibronectin and vitronectin expression in neighboring peritoneal mesothelial cells

Interleukin 6 receptor is an independent prognostic factor and a potential therapeutic target of ovarian cancer

Prognostic significance of bone marrow FDG uptake in patients with gynecological cancer

The significance of G-CSF expression and myeloid-derived suppressor cells in the chemoresistance of uterine cervical cancer

Potential of Integrin Inhibitors for Treating Ovarian Cancer: A Literature Review

In vivo loss-of-function screens identify KPNB1 as a new druggable oncogene in epithelial ovarian cancer

Pathophysiological Role and Potential Therapeutic Exploitation of Exosomes in Ovarian Cancer

Role of the Exosome in Ovarian Cancer Progression and Its Potential as a Therapeutic Target

The Highly Metastatic Nature of Uterine Cervical/Endometrial Cancer Displaying Tumor-Related Leukocytosis: Clinical and Preclinical Investigations

Loss of E-Cadherin Promotes Ovarian Cancer Metastasis via α5-Integrin, which Is a Therapeutic Target

Identification of Malignant Cell Populations Associated with Poor Prognosis in High-Grade Serous Ovarian Cancer Using Single-Cell RNA Sequencing

The hypoxia-related microRNA miR-199a-3p displays tumor suppressor functions in ovarian carcinoma

miR-92a Inhibits Peritoneal Dissemination of Ovarian Cancer Cells by Inhibiting Integrin α5 Expression

Preclinical Investigations of PM01183 (Lurbinectedin) as a Single Agent or in Combination with Other Anticancer Agents for Clear Cell Carcinoma of the Ovary

Paclitaxel exposure downregulates miR-522 expression and its downregulation induces paclitaxel resistance in ovarian cancer cells

Prostaglandin E2 produced by myeloid-derived suppressive cells induces cancer stem cells in uterine cervical cancer

Patient-Derived Exosomes as siRNA Carriers in Ovarian Cancer Treatment

Exosomal miR-1290 is a potential biomarker of high-grade serous ovarian carcinoma and can discriminate patients from those with malignancies of other histological types

Sleeping Beauty Transposon Mutagenesis Identifies Genes Driving the Initiation and Metastasis of Uterine Leiomyosarcoma

Foretinib (GSK1363089), an Orally Available Multikinase Inhibitor of c-Met and VEGFR-2, Blocks Proliferation, Induces Anoikis, and Impairs Ovarian Cancer Metastasis

Complicated pancreatic fistula after gynecologic surgery for left fallopian tube carcinosarcoma: A case report

mTOR Is a Promising Therapeutic Target Both in Cisplatin-Sensitive and Cisplatin-Resistant Clear Cell Carcinoma of the Ovary

Aktive Filter

Suchergebnisse filtern